Concepedia

Yumi Kubo

YK

Statistics

Publications

10

Citations

949

H-Index

10

Active since

2008

Affiliations

Amgen (United States)(Current)

Stanford University

University College London

University of Minnesota

Universitätsklinikum Aachen

Yumi Kubo is an author at Amgen (United States) specializing in cinacalcet therapy, medicine, and chronic kidney disease.

Publications per year

2008–2018

10

Publications

10

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis

Sharon M. Moe, Glenn M. Chertow, Patrick S. Parfrey et al. · Circulation · 2015 · 304 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial

David C. Wheeler, Gérard M. London, Patrick S. Parfrey et al. · Journal of the American Heart Association · 2014 · 139 citations · Full text

Medicine, Nephrology, Pharmacology +14

The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis

Jürgen Floege, Yumi Kubo, Anna Floege et al. · Clinical Journal of the American Society of Nephrology · 2015 · 138 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis

Francesco Locatelli, H. E. Abboud, Ángel L.M. de Francisco et al. · American Journal of Kidney Diseases · 2008 · 124 citations

Medicine, Nephrology, Pharmacology +10

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis

Patrick S. Parfrey, Tilman B. Drüeke, Geoffrey A. Block et al. · Clinical Journal of the American Society of Nephrology · 2015 · 96 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16

1–5 of 10